Fri, May 7, 2021

Oren Livnat Maintained (VYNE) at Strong Buy with Decreased Target to $198 on, May 7th, 2021

Oren Livnat of HC Wainwright & Co., Maintained "VYNE Therapeutics Inc." (VYNE) at Strong Buy with Decreased Target from $252 to $198 on, May 7th, 2021.

Oren, nor any peers, have made any analyst calls on VYNE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30